Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to 0.04.

  • Beam Therapeutics' Asset Utilization Ratio fell 85.66% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 85.66%. This contributed to the annual value of 0.05 for FY2024, which is 81.62% down from last year.
  • Latest data reveals that Beam Therapeutics reported Asset Utilization Ratio of 0.04 as of Q3 2025, which was down 2.25% from 0.04 recorded in Q2 2025.
  • Beam Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.29 during Q3 2024, with a 5-year trough of 0.00 in Q2 2021.
  • In the last 3 years, Beam Therapeutics' Asset Utilization Ratio had a median value of 0.06 in 2023 and averaged 0.13.
  • In the last 5 years, Beam Therapeutics' Asset Utilization Ratio skyrocketed by 176,929.34% in 2022 and then plummeted by 85.66% in 2025.
  • Quarterly analysis of 5 years shows Beam Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then climbed by 14.85% to 0.05 in 2022, then spiked by 506.87% to 0.27 in 2023, then slumped by 79.67% to 0.06 in 2024, then tumbled by 85.66% to 0.04 in 2025.
  • Its last three reported values are 0.04 in Q3 2025, 0.04 for Q2 2025, and 0.05 during Q1 2025.